Laura Gambino

Laura joins us with over 20 years of experience in the pharmaceutical industry in various phases of drug development. Previously she was Director of Project Management at Aerpio Pharmaceuticals from 2009 to 2019. While at Aerpio, Laura directed the development of a pipeline of novel small molecules and monoclonal antibodies for the treatment of diabetic retinopathy, glaucoma, and DME in preclinical to Phase 3 readiness trials. Before Aerpio, Laura was a Senior Clinical Project Manager at Quintiles Clinical Research (currently IQVIA) in Phase 2/3 Infectious Disease and Vaccine programs.

Before Quintiles, Laura spent many years at Pfizer Global Research & Development (previously Parke-Davis/Warner-Lambert). She later joined the Pfizer Global Project Management Research & Development group with focus on Infectious Diseases, Oncology, and Cardiovascular therapeutic areas in drug development.